-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, Haisco has entered the administrative approval stage with the imitation of perindopril indapamide tablets reported for production in Category 4 and is expected to win the first imitation
Perindopril and indapamide is a compound antihypertensive drug developed by French Servier.
According to data from Meinenet, in 2020, the total sales of perindopril and indapamide in China's urban public hospitals, county-level public hospitals, urban community centers, and township health centers (referred to as Chinese public medical institutions) and Chinese urban physical pharmacies will exceed 3 100 million yuan
At the physical pharmacy terminals in Chinese cities, the sales of perindopril and indapamide have been rising steadily, from 34.
Sales of perindopril and indapamide in physical pharmacies in cities in China (unit: ten thousand yuan)
Source: Mi Nei.
At present, only Servier has been approved for production of perindopril indapamide tablets in the domestic market, and Menova Tiankang and Haisco have submitted applications for perindopril indapamide tablets in imitation 4 categories
Data source: Mi Neiwang database, NMPA